-
1Academic Journal
المؤلفون: Yu. N. Krovko, A. V. Shmigelskiy, A. D. Аkhmedov, A. A. Shulgina, V. A. Lukshin, D. Yu. Usachev, Ю. Н. Кровко, А. В. Шмигельский, А. Д. Ахмедов, А. А. Шульгина, В. А. Лукшин, Д. Ю. Усачёв
المصدر: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 18, № 1 (2021); 84-92 ; Вестник анестезиологии и реаниматологии; Том 18, № 1 (2021); 84-92 ; 2541-8653 ; 2078-5658
مصطلحات موضوعية: тромбоз глубоких вен, enoxaparin, low molecular weight heparins, hepatotoxicity, deep vein thrombosis, эноксапарин, низкомолекулярные гепарины, гепатотоксичность
وصف الملف: application/pdf
Relation: https://www.vair-journal.com/jour/article/view/501/471; Государственный реестр лекарственных средств. Инструкция по медицинскому применению препарата Гепабене. [Электронный ресурс]. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=1629b696-7bc5-422b-a3ef-ee4eb400fde3&t= (дата обращения: 19.01.2020).; Государственный реестр лекарственных средств. Инструкция по медицинскому применению препарата Урсосан. [Электронный ресурс]. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=75ee02eb-a348-49eb-bd05-d74f693f081a&t= (дата обращения: 19.01.2020).; Государственный реестр лекарственных средств. Инструкция по применению лекарственного препарата для медицинского применения Креон 25000. [Электронный ресурс]. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8ac439cc-d78c-4d8f-9ffe-a085984979fb&t= (дата обращения: 19.01.2020).; Ивашкин В. Т., Барановский А. Ю., Райхельсон К. Л. и др. Лекарственные поражения печени (клинические рекомендации для врачей) // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. ‒ 2019. ‒ Т. 29, № 1. ‒ С. 101‒131. https://doi.org/10.22416/1382-4376-2019-29-1-101-131.; Пиманов С. И., Макаренко Е. В. Идиосинкразические лекарственные поражения печени: диагностика и лечение // Медицинский совет. ‒ 2017. ‒ № 5. ‒ С. 100‒107. https://doi.org/10.21518/2079-701X-2017-5-100-107.; Arora N., Goldhaber S. Z. Anticoagulants and transaminase elevation // Circulation. ‒ 2006. ‒ Vol. 113, № 15. ‒ P. 698‒702. https://doi.org/10.1161/CIRCULATIONAHA.105.603100.; Baker E. L., Loewenthal T., Salerno E. et al. Probable enoxaparin-induced hepatotoxicity // Am. J. Heal. Pharm. ‒ 2009. ‒ Vol. 66, № 7. ‒ P. 638‒641. https://doi.org/10.2146/ajhp080311.; Bosco M., Kish T. Hepatotoxicity with elevated bilirubin secondary to prophylactic doses of unfractionated heparin: a case report and review of heparin-induced hepatotoxicity // J. Pharm. Technol. ‒ 2019. ‒ Vol. 35, № 1. ‒ P. 36‒40. https://doi.org/10.1177/8755122518803363.; Cano-Paniagua A., Amariles P., Angulo N. et al. Epidemiology of drug-induced liver injury in a University Hospital from Colombia: updated RUCAM being used for prospective causality assessment // Ann. Hepatol. ‒ 2019. ‒ Vol. 18, № 3. ‒ P. 501‒507. https://doi.org/10.1016/j.aohep.2018.11.008.; Carlson M. K., Gleason P. P., Sen S. Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity // Pharmacotherapy. ‒ 2001. ‒ Vol. 21, № 1. ‒ P. 108‒113. https://doi.org/10.1592/phco.21.1.108.34436.; Danan G., Teschke R. RUCAM in drug and herb induced liver injury: the update // Int. J. Mol. Sci. ‒ 2015. ‒ Vol. 17, № 1. ‒ P. 1‒33. https://doi.org/10.3390/ijms17010014.; Di Saia P. J., Creasman W. T., Mannel R. S. et al. Clinical Gynecologic Oncology 9th edition. ‒ Philadelphia, PA. Elsevier, Inc. ‒ 2018. ‒ P. 1‒631.; Faraoni D., Comes R. F., Geerts W. et al. European guidelines on perioperative venous thromboembolism prophylaxis // Eur. J. Anaesthesiol. ‒ 2018. ‒ Vol. 35, № 2. ‒ P. 90‒95. https://doi.org/10.1097/EJA.0000000000000710.; Guidance for industry drug-induced liver injury: premarketing clinical evaluation. ‒ 2009. ‒ P. 1‒25. [Электронный ресурс]. URL: https://www.health.qld.gov.au/__data/assets/pdf_file/0023/147533/qh-gdl-951.pdf (дата обращения: 19.01.2020).; Guideline for anticoagulation and prophylaxis using low molecular weight heparin (LMWH) in adult inpatients. ‒ 2016. ‒ P. 1‒15. [Электронный ресурс]. URL: https://www.health.qld.gov.au/__data/assets/pdf_file/0023/147533/qh-gdl-951.pdf (дата обращения 19.01.2020).; Hahn K. J., Morales S. J., Lewis J. H. Enoxaparin-induced liver injury: case report and review of the literature and FDA adverse event reporting system (FAERS) // Drug. Saf. ‒ 2015. ‒ Vol. 2, № 1. ‒ P. 1‒11. https://doi.org/10.1007/s40800-015-0018-0.; Harrill A. H., Roach J., Fier I. et al. The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers // Clin. Pharmacol. Ther. ‒ 2012. ‒ Vol. 92, № 2. ‒ P. 214‒220. https://doi.org/10.1038/clpt.2012.40.; Hayashi P. H., Rockey D. C., Fontana R. J. et al. Death and liver transplantation within 2 years of onset of drug-induced liver injury // Hepatology. ‒ 2017. ‒ Vol. 66, № 4. ‒ P. 1275‒1285. https://doi.org/10.1002/hep.29283.; Hoofnagle J. H., Björnsson E. S. Drug-induced liver injury-types and phenotypes // N. Engl. J. Med. ‒ 2019. ‒ Vol. 381, № 3. ‒ P. 264‒273. https://doi.org/10.1056/NEJMra1816149.; Hui C., Yuen M., Ng I. O. et al. Low molecular weight heparin-induced liver toxicity // J. Clin. Pharmacol. ‒ 2001. ‒ Vol. 41. ‒ P. 691‒694. https://doi.org/10.1177/00912700122010465.; Kleiner D. E., Chalasani N. P., Lee W. M. et al. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations // Hepatology. ‒ 2014. ‒ Vol. 59, № 2. ‒ P. 661‒670. https://doi.org/10.1002/hep.26709.; Leo M., Ponziani F. R., Nesci A. et al. Low molecular weight heparin as cause of liver injury: case report and literature review // Eur. Rev. Med. Pharmacol. Sci. ‒ 2019. ‒ Vol. 23, № 17. ‒ P. 7649‒7654. https://doi.org/10.26355/eurrev_201909_18888.; Nguyen A., Dasgupta A., Wahed A. Management of hemostasis and coagulopathies for surgical and critically ill patients: an evidence-based approach 1st edition. ‒ Elsevier, Inc. ‒ 2016. ‒ P. 1-174.; Nissenson A. R., Fine R. N. Handbook of dialysis therapy. Philadelphia, PA. Elsevier, Inc. ‒ 2017. ‒ P. 1‒1171.; Robles-Diaz M., Isabel Lucena M., Kaplowitz N. et al. Use of hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury // Gastroenterology. ‒ 2014. ‒ Vol. 147, № 1. ‒ P. 109‒118.e5. https://doi.org/10.1053/j.gastro.2014.03.050.; Sonnenblick M., Oren A., Jacobsonn W. Hyper-transaminasemia with heparin therapy // Br. Med. J. ‒ 1975. ‒ Vol. 3. ‒ P. 77. https://doi.org/10.1136/bmj.3.5975.77.; Thakkar S., Li T., Liu Z. et al. Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicity // Drug. Discov. Today. ‒ 2019. ‒ Vol. 25, № 1. ‒ Р. 201‒208. https://doi.org/10.1016/j.drudis.2019.09.022.; Watkins P.B. Idiosyncratic drug-induced liver injury in patients: detection, severity assessment, and regulatory implications 1st edition // Advanc. Pharmacol. ‒ 2019. ‒ Vol. 85. ‒ P. 165‒193. https://doi.org/10.1016/bs.apha.2019.02.004.; https://www.vair-journal.com/jour/article/view/501
-
2Academic Journal
المؤلفون: A. A. Shulgina, V. A. Lukshin, E. I. Shults, A. I. Batalov, I. N. Pronin, D. Yu. Usachev, А. А. Шульгина, В. А. Лукшин, Е. И. Шульц, А. И. Баталов, И. Н. Пронин, Д. Ю. Усачев
المصدر: Medical Visualization; Том 25, № 2 (2021); 102-115 ; Медицинская визуализация; Том 25, № 2 (2021); 102-115 ; 2408-9516 ; 1607-0763
مصطلحات موضوعية: артериальный транзитный артефакт, cerebral perfusion, ASL, Moyamoya angiopathy, arterial transit artifact, церебральная перфузия, ангиопатия мойя-мойя
وصف الملف: application/pdf
Relation: https://medvis.vidar.ru/jour/article/view/883/661; https://medvis.vidar.ru/jour/article/downloadSuppFile/883/833; https://medvis.vidar.ru/jour/article/downloadSuppFile/883/834; https://medvis.vidar.ru/jour/article/downloadSuppFile/883/835; https://medvis.vidar.ru/jour/article/downloadSuppFile/883/836; https://medvis.vidar.ru/jour/article/downloadSuppFile/883/837; Lee M., Zaharchuk G., Guzman R., Achrol A., Bell-Stephens T., Steinberg G.K. Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg. Focus. 2009; 26 (4): E5. https://doi.org/10.3171/2009.1.FOCUS08300; Grubb R.L. Jr., Powers W.J., Clarke W.R., Videen T.O., Adams H.P. Jr., Derdeyn C.P.; Carotid Occlusion Surgery Study Investigators. Surgical results of the Carotid Occlusion Surgery Study. J. Neurosurg. 2013; 118 (1): 25–33. https://doi.org/10.3171/2012.9.JNS12551; Wintermark M., Sesay M., Barbier E., Borbély K., Dillon W.P., Eastwood J.D., Glenn T.C., Grandin C.B., Pedraza S., Soustiel J.F., Nariai T., Zaharchuk G., Caillé J.M., Dousset V., Yonas H. Comparative overview of brain perfusion imaging techniques. Stroke. 2005; 36 (9): 11. https://doi.org/10.1161/01.STR.0000177884.72657.8b; Latchaw R.E., Yonas H., Pentheny S.L., Gur D. Adverse reactions to xenon-enhanced CT cerebral blood flow determination. Radiology. 1987; 163 (1): 251–254. https://doi.org/10.1148/radiology.163.1.3823444; Detre J.A., Alsop D.C., Vives L.R., Maccotta L., Teener J.W., Raps E.C. Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology. 1998; 50 (3): 633–641. https://doi.org/10.1212/wnl.50.3.633; Goetti R., Warnock G., Kuhn F.P., Guggenberger R., O'Gorman R., Buck A., Khan N., Scheer I. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spinlabeling-MRI and H(2)[(15)O]-PET. Am. J. Neuroradiol. 2014; 35 (5): 1022–1028. https://doi.org/10.3174/ajnr.A3799; Goetti R., O'Gorman R., Khan N., Kellenberger C.J., Scheer I. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI. Neuroradiology. 2013; 55 (5): 639–647. https://doi.org/10.1007/s00234-013-1155-8; Noguchi T., Kawashima M., Irie H., Ootsuka T., Nishihara M., Matsushima T., Kudo S. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging. Eur. J. Radiol. 2011; 80 (3): 18. https://doi.org/10.1016/j.ejrad.2011.01.016; Petcharunpaisan S., Ramalho J., Castillo M. Arterial spin labeling in neuroimaging. Wld J. Radiol. 2010; 2 (10): 384–398. https://doi.org/10.4329/wjr.v2.i10.384; Amukotuwa S.A., Yu C., Zaharchuk G. 3D Pseudocontinuous arterial spin labeling in routine clinical practice: A review of clinically significant artifacts. J. Magn. Reson. Imaging. 2016; 43 (1): 11–27. https://doi.org/10.1002/jmri.24873; Kwah L.K., Diong J. National Institutes of Health Stroke Scale (NIHSS). J. Physiother. 2014; 60 (1): 61. https://doi.org/10.1016/j.jphys.2013.12.012; Biagi L., Abbruzzese A., Bianchi M.C., Alsop D.C., Del Guerra A., Tosetti M. Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. J. Magn. Reson. Imaging. 2007. 25 (4): 696–702. https://doi.org/10.1002/jmri.20839; Kohno N., Okada K., Yamagata S., Takayoshi H., Yamaguchi S. The clinical significance of arterial transit artifact on arterial spin labeling in patients with acute ischemic stroke. AME Medical J. 2017; 2 (9). https://doi.org/10.21037/amj.2017.08.27; Mutke M.A., Madai V.I., von Samson-Himmelstjerna F.C., Zaro Weber O., Revankar G.S., Martin S.Z., Stengl K.L., Bauer M., Hetzer S., Günther M., Sobesky J. Clinical evaluation of an arterial-spin-labeling product sequence in steno-occlusive disease of the brain. PLoS One. 2014; 9 (2): e87143. https://doi.org/10.1371/journal.pone.0087143; Suzuki J., Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch. Neurol. 1969; 20 (3): 288–299. https://doi.org/10.1001/archneur.1969.00480090076012; Togao O., Mihara F., Yoshiura T., Tanaka A., Noguchi T., Kuwabara Y., Kaneko K., Matsushima T., Honda H. Cerebral hemodynamics in Moyamoya disease: correlation between perfusion-weighted MR imaging and cerebral angiography. Am. J. Neuroradiol. 2006; 27 (2): 391–397.; Baltsavias G., Khan N., Valavanis A. The collateral circulation in pediatric moyamoya disease. Childs Nerv. Syst. 2015; 31 (3): 389–398. https://doi.org/10.1007/s00381-014-2582-5; Houkin K., Nakayama N., Kuroda S., Nonaka T., Shonai T., Yoshimoto T. Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc. Dis. 2005; 20 (5): 347–354. https://doi.org/10.1159/000087935; Sugino T., Mikami T., Miyata K., Suzuki K., Houkin K., Mikuni N. Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease. J. Stroke Cerebrovasc. Dis. 2013; 22 (6): 811–816. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.05.010; Quon J.L., Kim L.H., Lober R.M., Maleki M., Steinberg G.K., Yeom K.W. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome. J. Neurosurg. Pediatr. 2019; 23 (4): 486–492. https://doi.org/10.3171/2018.11.PEDS18498; Ha J.Y., Choi Y.H., Lee S., Cho Y.J., Cheon J.E., Kim I.O., Kim W.S. Arterial spin labeling mri for quantitative assessment of cerebral perfusion before and after cerebral revascularization in children with moyamoya disease. Korean J. Radiol. 2019; 20 (6): 985–996. https://doi.org/10.3348/kjr.2018.0651; Zaharchuk G., Do H.M., Marks M.P., Rosenberg J., Moseley M.E., Steinberg G.K. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke. 2011; 42 (9): 2485–2491. https://doi.org/10.1161/STROKEAHA.111.616466; Lee S., Yun T.J., Yoo R.E., Yoon B.W., Kang K.M., Choi S.H., Kim J.H., Kim J.E., Sohn C.H., Han M.H. Monitoring cerebral perfusion changes after revascularization in patients with moyamoya disease by using arterial spinlabeling MR imaging. Radiology. 2018; 288 (2): 565–572. https://doi.org/10.1148/radiol.2018170509; Chalela J.A., Alsop D.C., Gonzalez-Atavales J.B., Maldjian J.A., Kasner S.E., Detre J.A. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke. 2000; 31 (3): 680–687. https://doi.org/10.1161/01.str.31.3.680; Noguchi T., Kawashima M., Nishihara M., Hirai T., Matsushima T., Irie H. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings. Eur. J. Radiol. 2013; 82 (12): 1. https://doi.org/10.1016/j.ejrad.2013.08.040; Fan A.P., Guo J., Khalighi M.M., Gulaka P.K., Shen B., Park J.H., Gandhi H., Holley D., Rutledge O., Singh P., Haywood T., Steinberg G.K., Chin F.T., Zaharchuk G. Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/ MRI Study. Stroke. 2017; 48 (9): 2441–2449. https://doi.org/10.1161/STROKEAHA.117.017773; https://medvis.vidar.ru/jour/article/view/883
-
3Academic Journal
المؤلفون: A. A. Kurbasov, A. V. Shmigelskiy, A. D. Аkhmedov, V. A. Lukshin, D. Yu. Usachev, А. А. Курбасов, А. В. Шмигельский, А. Д. Ахмедов, В. А. Лукшин, Д. Ю. Усачёв
المصدر: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 17, № 5 (2020); 95-105 ; Вестник анестезиологии и реаниматологии; Том 17, № 5 (2020); 95-105 ; 2541-8653 ; 2078-5658
مصطلحات موضوعية: интраоперационная гипертензия, hormone-active carotid glomus paragangliomas, anesthetic support, intraoperative hypertension, гормонально-активные параганглиомы каротидного гломуса, анестезиологическое обеспечение
وصف الملف: application/pdf
Relation: https://www.vair-journal.com/jour/article/view/471/451; Коваль И. В. Параганглиомы основания черепа: Клиника, диагностика и тактика лечения: Дис. … канд. мед. наук. ‒ М., 1989.; Куликов А. С., Лубнин А. Ю. Дексмедетомидин: новые возможности в анестезиологии // Анестезиология и реаниматология. ‒ 2013. ‒ Т. 58, № 1. ‒ С. 37‒41.; Лубнин А. Ю., Цейтлин А. М., Коваль И. В. и др. Анестезиологическое обеспечение при удалении опухоли югулярного гломуса. Первый опыт применения урапидила // Анестезиология и реаниматология. ‒ 1996. Т. 41, № 2. ‒ С. 50‒53.; Усачев Д. Ю., Арустамян С. Р., Лубнин А. Ю. и др. Комбинированное хирургическое лечение каротидной параганглиомы // Журнал Вопросы нейрохирургии им. ак. Н. Н. Бурденко. ‒ 2004. ‒ T. 68, № 3. ‒ С. 27‒30.; Ahmad T., Patil S., Pasarad A. K. et al. Paraganglioma masquerading as acute myocardial infarction and cardiogenic shock // Indian Heart J. ‒ 2016. ‒ Vol. 68, Suppl. 2. ‒ P. 258‒263.; Ali E. M., Selim O. A., Ozgul U. et al. Dexmedetomidine, Remifentanil, and Sevoflurane in the perioperative management of a patient during a laparoscopic pheochromocytoma resection // J. Cardiothor. Vasc. Anesthesia. 2015. ‒ Vol. 29, № 6. ‒ Р. 79‒80.; Amato B., Serra R., Fappiano F. et al. Surgical complications of carotid body tumors surgery: a review // Int. Angiol. ‒ 2015. ‒ Vol. 34, № 6, Suppl. 1. ‒ P. 15‒22.; Baysal A., Sasmazel A., Bugra O. et al. Necessity of adequate monitoring during carotid body tumors // Anatol. J. Cardiol. ‒ 2010. ‒ Vol. 10, № 4. ‒ P. 380‒381.; Berdal P., Braaten M., Cappelen C. Jr. et al. Noradrenaline-adrenaline producing nonchromaffin paraganglioma // Acta. Med. Scand. ‒ 1962. ‒ Vol. 172, № 2. P. 249‒257.; Bryskin R., Weldon B. C. Dexmedetomidine and magnesium sulfate in the perioperative management of a child undergoing laparoscopic resection of bilateral pheochromocytomas // J. Clin. Anesthesia. ‒ 2010. ‒ Vol. 22, № 2. P. 126‒129.; Chen Y., Li Y., Liu J. et al. The clinical characteristics and outcomes of carotid body tumors in Chinese patients: A STROBE-compliant observational study // Medicine (Baltimore). ‒ 2020. ‒ Vol. 99, № 3. ‒ P. e18824.; Clarke A. D., Matheson H., Boddie H. G. Removal of catecholamine-secreting chemodectoma. The use of neuroleptanaesthesia, adrenergic blockade and sodium nitroprusside // Anaesthesia. ‒ 1976. ‒ Vol. 31, № 9. ‒ P. 1225‒1230.; Cobb A. N., Barkat A., Daungjaiboon W. et al. Carotid body tumor resection: just as safe without preoperative embolization // Ann. Vasc. Surg. ‒ 2018. Vol. 46. ‒ P. 54‒59.; Connor D., Boumphrey S. Perioperative care of phaeochromocytoma // BJA Education. ‒ 2016. ‒ Vol. 16, № 5. ‒ P. 153‒158.; Dixon J. L., Atkins M. D., Bohannon W. T. et al. Surgical management of carotid body tumors: a 15-year single institution experience employing an interdisciplinary approach // Proc. (Bayl. Univ. Med. Cent.). ‒ 2016. ‒ Vol. 29, № 1. ‒ P. 16‒20.; Duke W. M., Phillips M. W., Donald J. M. Jr. et al. A Norepinephrine-secreting glomic tissue tumor (chemodectoma) // JAMA. ‒ 1965. ‒ Vol. 193, № 1. ‒ P. 20‒22.; Elshafie O., Al Badaai Y., Alwahaibi K. et al. Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide // Endocrinology, Diabetes & Metabolism Case Reports. ‒ 2014. ‒ № 1. ‒ P. 140051.; Farage M., Costa M. A., Godoy-Matos A. F. A rare case of Cushing syndrome by cyclic ectopic-ACTH // Arquivos Brasileiros de Endocrinologia & Metabologia. ‒ 2012. ‒ Vol. 56, № 5. ‒ P. 324‒330.; Farr H. W. Carotid body tumors: a 40-year study // CA Cancer J. Clin. ‒ 1980. Vol. 30, № 5. ‒ P. 260‒265; Giavarini A., Chedid A., Bobrie G. et al. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma // Heart. 2013. ‒ Vol. 99, № 19. ‒ P. 1438‒1444.; Glenner G. G., Crout J. R., Roberts W. C. A functional carotid-body-like tumor. Secreting levarterenol // Arch. Pathol. ‒ 1962. ‒ Vol. 73. ‒ P. 230‒240.; Granell M., Tommasi M., Ubeda J. et al. Anesthesia for carotid paraganglioma exeresis. Report of 3 cases // Rev. Esp. Anestesiol. Reanim. ‒ 2001. ‒ Vol. 48, № 8. ‒ P. 387‒392.; Guardo L. A., Gala C. C., Calvo A. R. et al. Known difficult airway in a patient with pheochromocytoma: a case report // J. Clin. Anesthesia. ‒ 2016. ‒ Vol. 35. ‒ P. 411‒414.; Hallett J. W., Nora J. D., Hollier L. H. et al. Trends in neurovascular complications of surgical management for carotid body and cervical paraganglionmas: A fifty-year experience with 153 tumors // J. Vasc. Surgery. ‒ 1988. ‒ Vol. 7, № 2. ‒ P. 284‒291.; Hirano S., Shoji K., Kojima H. et al. Dopamine-secreting carotid body tumor // Am. J. Otolaryngol. ‒ 1998. ‒ Vol. 19, № 6. ‒ P. 412‒416.; Hoang V. T., Trinh C. T., Lai T. A. K. et al. Carotid body tumor: a case report and literature review // J. Radiol. Case Reports. ‒ 2019. ‒ Vol. 13, № 8. ‒ P. 19‒30.; Hu K., Persky M. S. Treatment of head and neck paragangliomas // Cancer Control. ‒ 2016. ‒ Vol. 23, № 3. ‒ P. 228‒241.; Hua Q., Xu Z., Jiang Y. Diagnosis and surgical treatment of carotid body tumor: A retrospective analysis of 58 patients // Oncology Letters. ‒ 2017. ‒ Vol. 14, № 3. ‒ P. 3628‒3632.; Jagtap S. R., Bakhshi R. G., Khatavkar S. S. et al. Carotid body tumour excision: Anaesthetic challenges and review of literature // Indian J. Anaesth. ‒ 2013. Vol. 57, № 1. ‒ P. 76‒78.; Jeffery J., Devendra D., Farrugia J. et al. Increased urinary dopamine excretion in association with bilateral carotid body tumours ‒ clinical, biochemical and genetic findings // Ann. Clin. Biochem. ‒ 2006. ‒ Vol. 43, № 2. ‒ P. 156‒160.; Joseph T., Shetty N., Chaudhuri S. et al. Child with bilateral pheochromocytoma and a surgically solitary kidney: Anesthetic challenges // Saudi J. Anaesthesia. 2013. ‒ Vol. 7, № 2. ‒ P. 197‒199.; LaMuraglia G. M., Fabian R. L., Brewster D. C. et al. The current surgical management of carotid body paragangliomas // J. Vasc. Surgery. ‒ 1992. ‒ Vol. 15, № 6. ‒ P. 1038‒1045.; Lenders J. W. M., Duh Q. Y., Eisenhofer G. et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline // J. Clin. Endocrinology & Metabolism. ‒ 2014. ‒ Vol. 99, № 6. ‒ P. 1915‒1942.; Lopez C. T., Hernandez M. V., Briz S. E. et al. Anesthesia in head and neck paragangliomas // Acta. Otorrinolaringol. Esp. ‒ 2009. ‒ Vol. 60, Suppl. 1. ‒ P. 76‒79.; Malliwal A., Mohite S., Doshi N. et al. Anaesthetic challenges in carotid body tumour resection: a case report and review of literature // Intern. J. Res. Med. Sci. ‒ 2015. ‒ Vol. 3, № 12. ‒ P. 3897‒3900.; Matticari S., Credi G., Pratesi C. et al. Diagnosis and surgical treatment of the carotid body tumors // J. Cardiovasc. Surg. (Torino). ‒ 1995. ‒ Vol. 36, № 3. ‒ P. 233‒239.; Naik S. M., Shenoy A. M., Nanjundappa H. R. et al. Paragangliomas of the carotid body: current management protocols and review of literature // Indian J. Surg. Oncol. ‒ 2013. ‒ Vol. 4, № 3. ‒ P. 305‒312.; Ng D. W., Yam C. I., Wong L. T. et al. An anaesthesia perspective on carotid body tumour (CBT) excision: A twenty-year case series at the Singapore General Hospital // J. Perioper. Pract. ‒ 2017. ‒ Vol. 27, № 10. ‒ P. 228‒233.; Offergeld C., Brase C., Yaremchuk S. et al. Head and neck paragangliomas: clinical and molecular genetic classification // Clinics (Sao Paulo). ‒ 2012. Vol. 67, Suppl. 1. ‒ P. 19‒28.; Puggioni A., Delis K. T., Fields C. E. et al. Large symptomatic carotid body tumor resection aided by preoperative embolization and mandibular subluxation // Perspect. Vasc. Surg. Endovasc. Ther. ‒ 2005. ‒ Vol. 17, № 1. ‒ P. 21‒28.; Ramachandran R., Rewari V. Current perioperative management of pheochromocytomas // Indian J. Urol. ‒ 2017. ‒ Vol. 33, № 1. ‒ P. 19‒25.; Schumann R., Hudcova J. Dexmedetomidine infusion during surgery in patients with a pheochromocytoma // Acta Anaesthesiologica Scandinavica. 2010. ‒ Vol. 54, № 3. ‒ P. 393‒394.; Singh S., Singh A. Dexmedetomidine induced catecholamine suppression in pheochromocytoma // J. Nat. Sci. Biol. Med. ‒ 2014. ‒ Vol. 5, № 1. ‒ P. 182‒183.; Snitzer J. L., Sheeler L. R., Bravo E. L. et al. A carotid body and glomus jugulare paraganglioma secreting norepinephrine // Endocr. Pract. ‒ 1995. ‒ Vol. 1, № 2. ‒ P. 82‒85.; Texakalidis P., Charisis N., Giannopoulos S. et al. Role of preoperative embolization in carotid body tumor surgery: a systematic review and meta-analysis // World Neurosurg. ‒ 2019. ‒ Vol. 129. ‒ P. 503‒513.; Whitwam J. G. APUD cells and the apudomas. A concept relevant to anaesthesia and endocrinology // Anaesthesia. ‒ 1977. ‒ Vol. 32, № 9. ‒ P. 879‒888.; Williams M. D. Paragangliomas of the Head and neck: an overview from diagnosis to genetics // Head Neck Pathol. ‒ 2017. ‒ Vol. 11, № 3. ‒ P. 278‒287.; Wright D. J., Pandya A., Noel F. Anaesthesia for carotid body tumour resection. A case report and review of the literature // Anaesthesia. ‒ 1979. ‒ Vol. 34, № 8. ‒ P. 806‒808.; Zeng G., Feng H., Zhao J. et al. Clinical characteristics and strategy for treatment of functional carotid body tumours // Intern. J. Oral Maxillofacial Surgery. 2013. ‒ Vol. 42, № 4. ‒ P. 436‒439.; Zeng G., Zhao J., Ma Y., et al. A Comparison between the treatments of functional and nonfunctional carotid body tumors // Ann. Vasc. Surgery. 2012. ‒ Vol. 26, № 4. ‒ P. 506‒510.; Zhang W. D., Zhang D. S., Liu J. J. et al. Clinical analysis of 19 carotid body tumors // Shanghai J. Stomatol. ‒ 2007. ‒ Vol. 16, № 6. ‒ P. 660‒664.; https://www.vair-journal.com/jour/article/view/471